Non-transgenic yeast modification using site-directed mutagenesis to produce squalene
Method currently not considered a GMO approach in the U.S. and EU
Pilot-scale facility started up in 2013; anticipating commercial scale squalene production at a toll refiner in H2 2014
This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
Genetically modifies E. coli to convert gas feedstocks like CO2 and methane into higher‑value chemicals
Products of interest include 3‑hydroxypropionate (3‑HP) and its derivatives as well as novel polyhydroxyalkanoates (PHAs); developing other products with partners but would not disclose
Not part of subscription
Develops routes to high‑value‑added chemical products from renewable raw materials using a combination of fermentation and catalytic processes
Currently has four main bioproducts in its portfolio including acetoin, 2,3‑butanediol (2,3‑BDO), methyl ethyl ketone (MEK), and 1,3‑butadiene (1,3‑BD...
To read more,
Renewable, biodegradable, and higher‑performing alternatives to incumbent petroleum‑based surfactants; the company expects more than 50% cost savings relative to other biosurfactant production routes
Has demonstrated its technology for sophorolipids in a 150‑L pilot reactor; recently launched a...
To read more,